Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40PRL | ISIN: US62459M2061 | Ticker-Symbol:
NASDAQ
30.06.25 | 21:19
0,680 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MOVANO INC Chart 1 Jahr
5-Tage-Chart
MOVANO INC 5-Tage-Chart

Aktuelle News zur MOVANO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.06.Movano Inc. - 8-K, Current Report1
MOVANO Aktie jetzt für 0€ handeln
23.05.Movano Health faces Nasdaq compliance issue over report delay1
23.05.Movano Health receives notification of deficiency from Nasdaq1
23.05.Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q160PLEASANTON, Calif., May 23, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)(the "Company") announced today that it received a notice (the "Notice") from the...
► Artikel lesen
21.05.Movano Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB1
19.05.Movano Inc. - 8-K, Current Report1
16.05.Movano Health explores strategic alternatives to enhance value1
22.04.Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements99Leveraging the Company's System-on-a-Chip (SoC), the clinical study results are another significant step forward in commercializing a cuffless, radio frequency (RF)-enabled blood pressure...
► Artikel lesen
09.04.Movano Inc. - 10-K, Annual Report1
04.02.Movano Health kicks off cuffless blood pressure device study2
02.12.24Movano Health Receives FDA Clearance for EvieMED Ring184Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif., Dec. 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer...
► Artikel lesen
14.11.24Movano Health Reports Q3 2024 Financial Results and Provides Business Update142Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities...
► Artikel lesen
07.11.24Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device148New hardware boasts significant improvements to reduce noise and generate higher fidelity signals PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano Health...
► Artikel lesen
04.11.24Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED150Company remains optimistic on the potential for this pioneering healthcare solution PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ: MOVE)...
► Artikel lesen
04.11.24Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split166Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Nov. 4, 2024...
► Artikel lesen
31.10.24Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split134Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/...
► Artikel lesen
25.10.24Movano Health Announces Reverse Stock Split209Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024 PLEASANTON, Calif., Oct. 25, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)...
► Artikel lesen
24.10.24Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase127A successful response to requests for additional information would bring the Company one step closer to introducing this pioneering healthcare product to the market PLEASANTON, Calif., Oct. 24,...
► Artikel lesen
10.10.24Movano Health Provides Update on FDA Review of EvieMED Ring166The Company continues to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif., Oct. 10, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced...
► Artikel lesen
14.08.24Movano Health Reports Q2 2024 Financial Results and Provides Business Update241Prepares for September 17, 2024, Evie Ring back in stock dateAnnounces brand partnership with digital creator Heidi D'AmelioFocuses on launch of EvieMED and securing B2B opportunitiesConference Call...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen